{
    "code": "02022031",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02022031",
    "time": "2016-11-18 20:07:55",
    "許可證字號": "衛署藥輸字第022031號",
    "註銷狀態": "已註銷",
    "註銷日期": "99\/09\/21",
    "註銷理由": "未展延而逾期者",
    "有效日期": "97\/01\/12",
    "發證日期": "87\/01\/12",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202203100",
    "中文品名": "納福康點眼液０．０１２％（鹽酸　甲嘧坐　）",
    "英文品名": "NAPHCON STERILE OPHTHALMIC SOLUTION 0.012%(NAPHAZOILINE HCL )",
    "適應症": "暫時緩解因輕微眼部刺激所引起之不適或眼睛紅。",
    "劑型": "472點眼液劑",
    "包裝": "塑膠容器裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "17醫師藥師藥劑生指示藥",
    "主成分略述": [
        "NAPHAZOLINEHCL"
    ],
    "限制項目": "02輸　入",
    "申請商名稱": "1304601100  瑞士商愛爾康大藥廠股份有限公司台灣分公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F050037000  S.A. ALCON-COUVREUR N.V.",
        "製造廠廠址": "RIJKSWEG 14, 2870 PUURS, BELGIUM",
        "製造廠公司地址": "",
        "": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses,put up in measured doses or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1212001910",
            "成分名稱": "NAPHAZOLINE HCL",
            "含量描述": "0.12",
            "含量": "0.1200000000",
            "單位": "MG"
        }
    ]
}